These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29677628)

  • 1. Circulating metabolomic profile can predict dyslipidemia in HIV patients undergoing antiretroviral therapy.
    Rodríguez-Gallego E; Gómez J; Domingo P; Ferrando-Martínez S; Peraire J; Viladés C; Veloso S; López-Dupla M; Beltrán-Debón R; Alba V; Vargas M; Castellano AJ; Leal M; Pacheco YM; Ruiz-Mateos E; Gutiérrez F; Vidal F; Rull A;
    Atherosclerosis; 2018 Jun; 273():28-36. PubMed ID: 29677628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A baseline metabolomic signature is associated with immunological CD4+ T-cell recovery after 36 months of antiretroviral therapy in HIV-infected patients.
    Rodríguez-Gallego E; Gómez J; Pacheco YM; Peraire J; Viladés C; Beltrán-Debón R; Mallol R; López-Dupla M; Veloso S; Alba V; Blanco J; Cañellas N; Rull A; Leal M; Correig X; Domingo P; Vidal F
    AIDS; 2018 Mar; 32(5):565-573. PubMed ID: 29280761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of ART on the dynamics of lipid profiles in Chinese Han HIV-infected patients: comparison between NRTI/NNRTI and NRTI/INSTI.
    Liu S; Wei B; Liang W; Chen T; Deng L; Zhao M; Wan J
    Front Public Health; 2023; 11():1161503. PubMed ID: 37181701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Retroviral Therapy Increases the Prevalence of Dyslipidemia in South African HIV-Infected Patients.
    Dave JA; Levitt NS; Ross IL; Lacerda M; Maartens G; Blom D
    PLoS One; 2016; 11(3):e0151911. PubMed ID: 26986065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dyslipidaemia in HIV-infected women on antiretroviral therapy. Analysis of 922 patients from the Spanish VACH cohort.
    Estrada V; Geijo P; Fuentes-Ferrer M; Alcalde ML; Rodrigo M; Galindo MJ; Muñoz A; Domingo P; Ribera E; Cosín J; Viciana P; Lozano F; Terrón A; Vergara A; Teira R; Muñoz-Sánchez J; Roca B; Sánchez T; López-Aldeguer J; Deig E; Vidal F; Pedrol E; Castaño-Carracedo M; Puig T; Garrido M; Suárez-Lozano I
    BMC Womens Health; 2011 Aug; 11():36. PubMed ID: 21816091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dyslipidemia among HIV-infected Patients with tuberculosis taking once-daily nonnucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in India.
    Padmapriyadarsini C; Ramesh Kumar S; Terrin N; Narendran G; Menon PA; Ramachandran G; Subramanyan S; Venkatesan P; Wanke C; Swaminathan S
    Clin Infect Dis; 2011 Feb; 52(4):540-6. PubMed ID: 21252141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of antiretroviral therapy on serum lipoprotein levels and dyslipidemias: a systematic review and meta-analysis.
    Nduka C; Sarki A; Uthman O; Stranges S
    Int J Cardiol; 2015 Nov; 199():307-18. PubMed ID: 26241636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of genetic factors on dyslipidemia in HIV-infected patients starting antiretroviral therapy.
    Egaña-Gorroño L; Martínez E; Cormand B; Escribà T; Gatell J; Arnedo M
    AIDS; 2013 Feb; 27(4):529-38. PubMed ID: 23262498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in lipids and lipoprotein particle concentrations after interruption of antiretroviral therapy.
    Lampe FC; Duprez DA; Kuller LH; Tracy R; Otvos J; Stroes E; Cooper DA; Hoy J; Paton NI; Friis-Møller N; Neuhaus J; Liappis AP; Phillips AN;
    J Acquir Immune Defic Syndr; 2010 Jul; 54(3):275-84. PubMed ID: 20658749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipids profile among ART-naïve HIV infected patients and men who have sex with men in China: a case control study.
    Wang Q; Ding H; Xu J; Geng W; Liu J; Guo X; Kang J; Li X; Jiang Y; Shang H
    Lipids Health Dis; 2016 Sep; 15(1):149. PubMed ID: 27600391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of single nucleotide polymorphisms with dyslipidemia in antiretroviral exposed HIV patients in a Ghanaian population: A case-control study.
    Obirikorang C; Acheampong E; Quaye L; Yorke J; Amos-Abanyie EK; Akyaw PA; Anto EO; Bani SB; Asamoah EA; Batu EN
    PLoS One; 2020; 15(1):e0227779. PubMed ID: 31929604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of genome-wide significant single-nucleotide polymorphisms and antiretroviral therapy to dyslipidemia in HIV-infected individuals: a longitudinal study.
    Rotger M; Bayard C; Taffé P; Martinez R; Cavassini M; Bernasconi E; Battegay M; Hirschel B; Furrer H; Witteck A; Weber R; Ledergerber B; Telenti A; Tarr PE;
    Circ Cardiovasc Genet; 2009 Dec; 2(6):621-8. PubMed ID: 20031643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The utility of non-HDL in managing dyslipidemia of stage 5 chronic kidney disease.
    Pennell P; Leclercq B; Delahunty MI; Walters BA
    Clin Nephrol; 2006 Nov; 66(5):336-47. PubMed ID: 17140163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lipid alterations and cardiovascular risk associated with antiretroviral therapy].
    Masiá-Canuto M; Bernal-Morell E; Gutiérrez-Rodero F
    Enferm Infecc Microbiol Clin; 2006 Dec; 24(10):637-48. PubMed ID: 17194390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of adiponectin/leptin ratio with carbohydrate and lipid metabolism parameters in HIV-infected patients during antiretroviral therapy.
    Tiliscan C; Arama V; Mihailescu R; Munteanu D; Iacob DG; Popescu C; Catana R; Negru A; Lobodan A; Arama SS
    Endocr Res; 2018 Aug; 43(3):149-154. PubMed ID: 29451987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly active antiretroviral therapy and dyslipidemia in people living with HIV/AIDS in Fako Division, South West Region of Cameroon.
    Nsagha DS; Weledji EP; Assob NJ; Njunda LA; Tanue EA; Kibu OD; Ayima CW; Ngowe MN
    BMC Cardiovasc Disord; 2015 Aug; 15():95. PubMed ID: 26315756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-line antiretroviral therapy and changes in lipid levels over 3 years among HIV-infected adults in Tanzania.
    Liu E; Armstrong C; Spiegelman D; Chalamilla G; Njelekela M; Hawkins C; Hertzmark E; Li N; Aris E; Muhihi A; Semu H; Fawzi W
    Clin Infect Dis; 2013 Jun; 56(12):1820-8. PubMed ID: 23449270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early increases in concentrations of total, LDL, and HDL cholesterol in HIV-infected children following new exposure to antiretroviral therapy.
    Sztam KA; Jiang H; Jurgrau A; Deckelbaum RJ; Foca MD
    J Pediatr Gastroenterol Nutr; 2011 Apr; 52(4):495-8. PubMed ID: 21206378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiretroviral treatment-induced dyslipidemia in HIV-infected patients is influenced by the APOC3-related rs10892151 polymorphism.
    Aragonès G; Alonso-Villaverde C; Pardo-Reche P; Rull A; Beltrán-Debón R; Rodríguez-Gallego E; Fernández-Sender L; Camps J; Joven J
    BMC Med Genet; 2011 Sep; 12():120. PubMed ID: 21939545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral therapy in HIV-positive men is associated with increased apolipoprotein CIII in triglyceride-rich lipoproteins.
    Rimland D; Guest JL; Hernández I; Del Rio C; Le NA; Brown WV
    HIV Med; 2005 Sep; 6(5):326-33. PubMed ID: 16156880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.